| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 84781 |
CAS: 863971-53-3,Fmoc-Val-Cit-PAB-PNP |
143 |
WYQ |
2024-12-19 |
| 84782 |
tris-苄基-DOTA tris-benzyl-DOTA |
176 |
h |
2024-12-19 |
| 84783 |
DOTA-DN(PTX)-BN DOTA-铃蟾肽功能化聚酰胺胺(PAMAM)树状大分子(DN)负载紫杉醇 |
164 |
h |
2024-12-19 |
| 84784 |
NH2-Sar10-COOH,ADC定制 |
170 |
wyh |
2024-12-19 |
| 84785 |
cas:1415328-95-8,NHPI-PEG4-C2-NHS ester |
185 |
zyl |
2024-12-19 |
| 84786 |
Gd-GlyMe-DOTA-全氟辛基甘露糖缀合物(Gadofluorine M) |
223 |
h |
2024-12-19 |
| 84787 |
MC-Val-Cit-PAB-PNP(CAS号:159857-81-5) |
177 |
WYQ |
2024-12-19 |
| 84788 |
Mal-Gly-Gly-L-Phe-N-[(carboxymethoxy)methyl]Glycinamide,ADC定制 |
145 |
wyh |
2024-12-19 |
| 84789 |
L-RNA寡核苷酸的功能化DOTA |
160 |
h |
2024-12-19 |
| 84790 |
MA-PEG4-Glu(t-Bu)-Val-Cit-PAB-PNP,在药物递送系统中具有广泛应用潜力 |
152 |
WYQ |
2024-12-19 |
| 84791 |
cas:1415800-42-8,perfluorophenyl 1-(2,5-dioxo-2H-pyrrol-1(5H)-yl)-3,6,9,12-tetraoxapentadecan-15-oate |
123 |
zyl |
2024-12-19 |
| 84792 |
羟基磺基琥珀酰亚胺DOTA(DOTA-OSSu) |
199 |
h |
2024-12-19 |
| 84793 |
Mal-PEG1-Val-Cit-OH,生物化学和药物研发领域有潜在应用 |
141 |
WYQ |
2024-12-19 |
| 84794 |
cas:1193111-39-5,1-(2,5-dioxopyrrolidin-1-yloxy)-1-oxo-4-(pyridin-2-yldisulfanyl)butane-2-sulfonic acid |
136 |
zyl |
2024-12-19 |
| 84795 |
DOTA-GGG-BN(7-14) |
160 |
h |
2024-12-19 |
| 84796 |
CAS: 108-30-5,Dihydrofuran-2,5-dione(丁二酸酐) |
206 |
WYQ |
2024-12-19 |
| 84797 |
cas:1884578-00-0 Boc-Val-Ala-PAB-PNP |
158 |
zyl |
2024-12-19 |
| 84798 |
DOTA-L22-异硫氰酸荧光素-依沙酸 |
137 |
h |
2024-12-19 |
| 84799 |
cas:2768446-73-5 DBCO-Val-Cit-PAB-MMAE |
139 |
zyl |
2024-12-19 |
| 84800 |
Boc-PEG4-Val-Ala-PAB,ADC定制 |
171 |
wyh |
2024-12-19 |
| 84801 |
CAS: 2504147-59-3,MC (C5)-Val-Cit |
144 |
WYQ |
2024-12-19 |
| 84802 |
CAS: 159857-80-4,MC-Val-Cit-PAB-OH |
197 |
WYQ |
2024-12-19 |
| 84803 |
cas:2055024-65-0 Azido-PEG3-Val-Cit-PAB-OH |
151 |
zyl |
2024-12-19 |
| 84804 |
Mal-Amide-PEG4-Val-Cit-PAB-OH,ADC定制 |
128 |
wyh |
2024-12-19 |
| 84805 |
CAS 2249935-92-8:Mal-PEG1-Val-Cit-PAB-PNP |
158 |
WYQ |
2024-12-19 |
| 84806 |
cas:2055024-54-7 Boc-PEG4-Val-Cit-PAB-OH 叔丁酯-四聚乙二醇-VAL-CIT-PAB-羟基 |
155 |
zyl |
2024-12-19 |
| 84807 |
Alkyne-Val-Cit-PAB-OH,ADC定制 |
200 |
wyh |
2024-12-19 |
| 84808 |
CAS 2395887-69-9:Mal-PEG2-Val-Cit-PAB-PNP |
158 |
WYQ |
2024-12-19 |
| 84809 |
CAS 1438853-35-0:Mal-PEG3-Val-Cit-PAB-PNP |
126 |
WYQ |
2024-12-19 |
| 84810 |
N-(Methyltetrazine-PEG4)-amido-PEG8-3,4-dithiophenolmaleimide |
235 |
zyl |
2024-12-19 |
| 84811 |
MC-beta-Ala-alpha-GlcA-MMAE,ADC定制 |
186 |
wyh |
2024-12-19 |
| 84812 |
Mal-PEG2-Val-Cit-PAB-OH(CAS: 2055041-38-6) |
160 |
WYQ |
2024-12-19 |
| 84813 |
cas:2100306-78-1,t-Butyl 3-(hydroxypropoxyl)-propanoate |
164 |
zyl |
2024-12-19 |
| 84814 |
NHS ester-PEG4-VC-PAB-Daunorubicin,ADC定制 |
177 |
wyh |
2024-12-19 |
| 84815 |
Mal-PEG3-Val-Cit-PAB-OH(CAS: 2727965-49-1) |
183 |
WYQ |
2024-12-19 |
| 84816 |
cas:1539292-60-8,tert-butyl 3-(4-(2-cyanoethynyl)phenylcarbamoyl)propylcarbamate |
128 |
zyl |
2024-12-19 |
| 84817 |
1281816-04-3,Lys-Nε-MCC-DM1,ADC定制 |
125 |
wyh |
2024-12-19 |
| 84818 |
cas:34450-18-5,Alkynyl Stearic Acid,17-十八炔酸 |
215 |
zyl |
2024-12-19 |
| 84819 |
Mal-PEG4-Val-Cit-PAB-OH(CAS: 2055041-39-7) |
181 |
WYQ |
2024-12-19 |
| 84820 |
1281816-04-3,Lys-Nε-MCC-DM1,ADC定制 |
144 |
wyh |
2024-12-19 |
| 84821 |
cas:120550-35-8,Biotin-PFP ester,五氟苯酚生物素酯 |
356 |
zyl |
2024-12-19 |
| 84822 |
MTS-ADO3A 三酸DOTA衍生物 |
202 |
h |
2024-12-19 |
| 84823 |
NHS-PEG2-NH-Xanomeline,ADC定制 |
162 |
wyh |
2024-12-19 |
| 84824 |
DOTA-DAsp-Tyr-Nle-Gly-Trp-Nle-Asp-Phe-NH2 DOTA-CCK |
208 |
h |
2024-12-19 |
| 84825 |
DOTA-MN2 2,2’-[4,10-双(2-{[2-(2-甲基-5-硝基-1H-咪唑-1-基)乙基]氨基}-2-氧乙基)-1,4,7,10-四氮杂环十二烷-1,7-二基]二乙酸 |
148 |
h |
2024-12-19 |